High-Dose Eye Supplements Slow AMD, But Not for Everyone
Ophthalmologists increasingly rely on a high-dose AREDS2 formulation to slow AMD progression, achieving about 18% fewer cases of late-stage AMD vs. the original mix; beta-carotene was removed due to lung-cancer risk, replaced with lutein and zeaxanthin. The benefit is specific to intermediate AMD in one or both eyes or advanced AMD in one eye; use must be tailored by a clinician, as high-dose vitamins can interact with meds and diet and genetic tests can't reliably predict who benefits.